PIM1 kinase as a target for cancer therapy

Author： Merkel Anna Lena Meggers Eric Ocker Matthias

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.4, 2012-04, pp. : 425-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance

Current Cancer Drug Targets, Vol. 14, Iss. 2, 2014-02 ,pp. : 105-114

Bentham Science Publishers

Access to resources Recommend Favorite

Downregulating sphingosine kinase-1 for cancer therapy

By Cuvillier Olivier

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 1009-1020

Informa Healthcare

Access to resources Recommend Favorite

The NK-1 Receptor: A New Target in Cancer Therapy

Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. : 909-921

Bentham Science Publishers

Access to resources Recommend Favorite

Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

By Hawinkels Lukas JAC Garcia de Vinuesa Amaya ten Dijke Peter

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1371-1383

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6670-6681

Bentham Science Publishers

Access to resources Recommend Favorite